Investing Profile

Brett Zbar

VCInvestor

Managing Director and Global Head of Life Sciences at General Atlantic

Your Intro Paths to Brett Zbar

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Brett is a member of

McKinsey & Company Network

141 CONNECTIONS

Yale University Network

126 CONNECTIONS

General Atlantic Network

37 CONNECTIONS

Harvard Medical School Network

20 CONNECTIONS

Find Brett Zbar on

Current Investing Position

General Atlantic Managing Partner

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Current Fund Size

$78B

Brett Zbar is on these Sector & Stage Rankings

Brett Zbar's Investments On Record (8)

Company	StageDateRound Size	Total Raised
Seaport Therapeutics	Series BOct 2024$230M	$330M
Co-investors: James Healy (Sofinnova Investments), Robert Nelsen (ARCH Venture Partners)
Pharvaris	Post Ipo EquityJun 2023$70M Series CNov 2020$80M Series BSep 2019$66M	$220M
Co-investors: Richard Gaster (venBio)
Javara Research	Series BApr 2022$40M	$40M
Centessa Pharmaceuticals	Series AFeb 2021$250M	$250M
Co-investors: Arjun Goyal (Vida Ventures)
Kinnate Biopharma	Series BDec 2019$75M Series AApr 2018$22M	$200M
Co-investors: Carl Gordon (OrbiMed), Michael Rome (Foresite Capital), Peter Kolchinsky (RA Capital)
Replimune Group	Series BSep 2017$55M	$85M
Co-investors: Jason Rhodes (Atlas Venture)
Venatorx Pharmaceuticals	Series BJul 2017$42M	$76M
Co-investors: Carlo Rizzuto (Versant Ventures), Martin Heidecker (AMR Action Fund)
Aragon Pharmaceuticals	Series DOct 2012$50M Series BApr 2010$22M	$80M
Co-investors: Carl Gordon (OrbiMed), Peter Svennilson (The Column Group), Josh Bilenker (Aisling Capital)